Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula
|ClinicalTrials.gov Identifier: NCT01315080|
Recruitment Status : Unknown
Verified March 2011 by Hospital Universitario Virgen de la Arrixaca.
Recruitment status was: Recruiting
First Posted : March 15, 2011
Last Update Posted : March 15, 2011
|Condition or disease|
To compare the results from a prospective observational database with two groups of patients:
- patients with MF treated by percutaneous drainage and saline solution.
- patients with MF treated by percutaneous drainage and saline solution plus percutaneous triamcinolone.
These patients are treated following usual clinical practice in our Department. All the procedures are made through an ultrasound-guided way. During the follow-up of these cases (clinical and with ultrasound) resolution rate will be registered by the same investigator.
The follow-up will be at least 6 months.
|Study Type :||Observational|
|Estimated Enrollment :||10 participants|
|Observational Model:||Case Control|
|Official Title:||Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula|
|Study Start Date :||March 2011|
|Estimated Primary Completion Date :||March 2012|
|Estimated Study Completion Date :||September 2012|
Percutaneous drainage and saline solution irrigation
Percutaneous drainage and saline solution irrigation plus percutaneous triamcinolone
- Resolution of mammillary fistula [ Time Frame: one year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01315080
|Contact: Juan D Berna, MD PhD||+34 968369500 ext firstname.lastname@example.org|
|Virgen de la Arrixaca University Hospital||Recruiting|
|Murcia, Spain, 30120|
|Contact: Juan D Berna, MD PhD +34 968369500 ext 29757 email@example.com|
|Principal Investigator:||Juan D Berna, MD PhD||Virgen de la Arrixaca University Hospital|